Characteristics and outcome of patients with solid tumour requiring admission to the intensive care unit. Usefulness of three severity score systems

To describe the characteristics and the evolution of patients with solid tumours admitted to the ICU and to identify factors associated with hospital mortality and to evaluate three illness severity scores. Descriptive study including 132 patients with solid tumour admitted to the ICU (2010–2016). D...

Full description

Saved in:
Bibliographic Details
Published in:Medicina clínica (English ed.) 2019-10, Vol.153 (7), p.270-275
Main Authors: Pérez Pérez, María Lucía, Gonzaga López, Ana, Balandín Moreno, Bárbara, Maximiano Alonso, Constanza, Palacios Castañeda, Diego, Ferreres Franco, José, García Sanz, Javier, Villanueva Fernández, Héctor, Valdivia de la Fuente, Miguel, Ortega López, Alfonso, Alcántara Carmona, Sara, Pérez Redondo, Marina, Royuela Vicente, Ana
Format: Article
Language:English
Subjects:
Escalas de gravedad
ICU
Mortalidad
Mortality
Prognosis
Pronóstico
Severity illness score
Solid tumour
Tumour sólido
Unidad de cuidados intensivos
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To describe the characteristics and the evolution of patients with solid tumours admitted to the ICU and to identify factors associated with hospital mortality and to evaluate three illness severity scores. Descriptive study including 132 patients with solid tumour admitted to the ICU (2010–2016). Demographics and cancer-related data, organ failures, life-supporting therapies and severity scores: APACHE II, SOFA and ICU Cancer Mortality Model (ICMM) were collected. There were 58 patients admitted for medical reasons and 74 for scheduled surgery. The ICU and hospital mortality rate were 12.9% and 19.7%, respectively. The medical reason for admission, the number of organ failures, and the need of life-supporting therapies were significantly associated with a higher mortality (p
ISSN:2387-0206
2387-0206
DOI:10.1016/j.medcle.2019.01.031